반응식
C(OC([N:8]1[CH2:13][CH2:12][N:11]([C:14]2[C:22]3[O:21][C:20]([C:23](=[O:25])[NH2:24])=[C:19]([CH2:26][C:27]4[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=4)[C:18]=3[CH:17]=[C:16]([CH3:33])[CH:15]=2)[CH2:10][CH2:9]1)=O)(C)(C)C.Cl>>[CH2:26]([C:19]1[C:18]2[CH:17]=[C:16]([CH3:33])[CH:15]=[C:14]([N:11]3[CH2:12][CH2:13][NH:8][CH2:9][CH2:10]3)[C:22]=2[O:21][C:20]=1[C:23]([NH2:24])=[O:25])[C:27]1[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=1참가 물질
3
실험 절차
4-(3-Benzyl-2-carbamoyl-5-methyl-benzofuran-7-yl)-piperazine-1-carboxylic acid tert-butyl ester was deprotected using ethanolic HCl, following the procedure of step 4 of Example 2, to provide 3-benzyl-5-methyl-7-piperazin-1-yl-benzofuran-2-carboxylic acid amide as a hydrochloride salt, (M+H)+ 350.
출처 및 근거
- ORD 기록
- ord-97a9fd022b854579aaf220708ba361e1
- 출처 데이터셋
- uspto-grants-2010_06
- 특허 번호
- US07741326B2
연결된 노트
불러오는 중…